SEER
Seer, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.94
−2.51%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 5.45x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.48x
- Price / sales
- 7.76x
- Price / cash flow
- -2.48x
Enterprise value
- Enterprise value
- -$23.0M
- EV / sales
- -1.66x
- EV / EBITDA
- 0.37x
- EV / EBIT
- 0.33x
- Market cap
- $107.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026